95 related articles for article (PubMed ID: 7226078)
1. Serum copper and zinc levels in melanoma patients.
Fisher GL; Spitler LE; McNeill KL; Rosenblatt LS
Cancer; 1981 Apr; 47(7):1838-44. PubMed ID: 7226078
[TBL] [Abstract][Full Text] [Related]
2. Serum copper and zinc measurement in patients with osteogenic sarcoma.
Breiter DN; Diasio RB; Neifeld JP; Roush ML; Rosenberg SA
Cancer; 1978 Aug; 42(2):598-602. PubMed ID: 307981
[TBL] [Abstract][Full Text] [Related]
3. Copper and zinc levels in serum from human patients with sarcomas.
Fisher GL; Byers VS; Shifrine M; Levin AS
Cancer; 1976 Jan; 37(1):356-63. PubMed ID: 764964
[TBL] [Abstract][Full Text] [Related]
4. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
Sanada S; Ogura K; Kiriyama T; Yoshida O
Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
[TBL] [Abstract][Full Text] [Related]
5. [Serum levels of copper and zinc in patients with lung cancer].
Altavilla G; Adamo V; Alafaci E; Buemi B; Chillemi S; La Scala R; Marabello G; Palmara D
Minerva Med; 1985 Nov; 76(44):2117-20. PubMed ID: 4069424
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
Wu HY
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
[TBL] [Abstract][Full Text] [Related]
7. Serum copper and zinc levels in patients with nasopharyngeal carcinoma.
Lian SL; Hsu HY; Lin SM
Taiwan Yi Xue Hui Za Zhi; 1989 Mar; 88(3):236-9. PubMed ID: 2794920
[TBL] [Abstract][Full Text] [Related]
8. Serum copper and zinc content in non-small cell lung cancer: abnormalities and clinical correlates.
Ferrigno D; Buccheri G; Camilla T
Monaldi Arch Chest Dis; 1999 Jun; 54(3):204-8. PubMed ID: 10441970
[TBL] [Abstract][Full Text] [Related]
9. Serum copper and zinc levels in patients with cervical cancer.
Chen CA; Hwang JL; Kuo TL; Hsieh CY; Huang SC
J Formos Med Assoc; 1990 Aug; 89(8):677-82. PubMed ID: 1981230
[TBL] [Abstract][Full Text] [Related]
10. Serum zinc levels are increased in melanoma patients.
Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
Melanoma Res; 1998 Jun; 8(3):273-7. PubMed ID: 9664150
[TBL] [Abstract][Full Text] [Related]
11. [The determination of Cu and Zn levels in the serum and gastric juice of patients with gastric cancer].
Wang CS
Zhonghua Wai Ke Za Zhi; 1989 Jul; 27(7):401-3, 444. PubMed ID: 2598740
[TBL] [Abstract][Full Text] [Related]
12. Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions.
Garofalo JA; Ashikari H; Lesser ML; Menendez-Botet C; Cunningham-Rundles S; Schwartz MK; Good RA
Cancer; 1980 Dec; 46(12):2682-5. PubMed ID: 7448705
[TBL] [Abstract][Full Text] [Related]
13. Serum zinc, serum copper, and the Cu/Zn ratio in patients with epidermoid cancers of the head and neck.
Garofalo JA; Erlandson E; Strong EW; Lesser M; Gerold F; Spiro R; Schwartz M; Good RA
J Surg Oncol; 1980; 15(4):381-6. PubMed ID: 7453188
[TBL] [Abstract][Full Text] [Related]
14. Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy.
Hsu HY; Lin SY; Huang CJ; Lian SL; Ho YH
Biol Trace Elem Res; 1994; 46(1-2):1-13. PubMed ID: 7888274
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole.
Shibata HR; Jerry LM; Lewis MG; Mansell PW; Capek A; Marquis G
Ann N Y Acad Sci; 1976; 277(00):355-66. PubMed ID: 1069555
[No Abstract] [Full Text] [Related]
16. [Serum copper and the copper:zinc ratio in patients with gastric cancer].
Mimata Y; Ujiie S; Himori T; Wakui A
Gan No Rinsho; 1986 Oct; 32(12):1533-9. PubMed ID: 3783978
[TBL] [Abstract][Full Text] [Related]
17. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
Quirt IC; Shelley WE; Pater JL; Bodurtha AJ; McCulloch PB; McPherson TA; Paterson AH; Prentice R; Silver HK; Willan AR
J Clin Oncol; 1991 May; 9(5):729-35. PubMed ID: 2016615
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effect of BCG, glucan and levamisole on B16 melanoma metastases.
Proctor JW; Auclair BG; Stokowski L; Mansell WA; Shibata H
Eur J Cancer (1965); 1977 Feb; 13(2):115-22. PubMed ID: 852486
[No Abstract] [Full Text] [Related]
19. Immunotherapy of malignant melanoma.
Terry WD
N Engl J Med; 1980 Nov; 303(20):1174-5. PubMed ID: 6999351
[No Abstract] [Full Text] [Related]
20. [Laboratory markers of melanoma progression].
Bánfalvi T; Edesné MB; Gergye M; Udvarhelyi N; Orosz Z; Gilde K; Kremmer T; Ottó S; Tímár J
Magy Onkol; 2003; 47(1):89-104. PubMed ID: 12704461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
